Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Oncoimmunology
|
April 2, 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Maria Georganaki, Mohanraj Ramachandran, Sander Tuit, et al.
JCI Insight
|
July 6, 2021
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing
Yuan Xie, Liqun He, Roberta Lugano, et al.
Neuro-Oncology
|
August 4, 2021
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma
Hua Huang, Maria Georganaki, Lei Liu Conze, et al.
Cancer Cell
|
May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cell Reports
|
April 16, 2025
KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
Maximiliano Arce, Iza Erzar, Fan Yang, et al.
Science Translational Medicine
|
July 29, 2021
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Yi Sun, Wei Chen, Robert J Torphy, et al.
Cancers
|
August 7, 2019
Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
Maximiliano Arce, Mauricio P Pinto, Macarena Galleguillos, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Oncoimmunology
|
April 2, 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Maria Georganaki, Mohanraj Ramachandran, Sander Tuit, et al.
JCI Insight
|
July 6, 2021
Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing
Yuan Xie, Liqun He, Roberta Lugano, et al.
Neuro-Oncology
|
August 4, 2021
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma
Hua Huang, Maria Georganaki, Lei Liu Conze, et al.
Cancer Cell
|
May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Mohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Cell Reports
|
April 16, 2025
KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation
Maximiliano Arce, Iza Erzar, Fan Yang, et al.
Science Translational Medicine
|
July 29, 2021
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Yi Sun, Wei Chen, Robert J Torphy, et al.
Cancers
|
August 7, 2019
Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
Maximiliano Arce, Mauricio P Pinto, Macarena Galleguillos, et al.
Page
of 3